Niki BioSolutions, Inc. (NIKI) Assets (2017 - 2025)

Niki BioSolutions' (NIKI) quarterly Assets came in at $481065.0 in Q4 2025, up 17.13% on a QoQ basis from $410699.0 in Q3 2025.

Niki BioSolutions, Inc. (NIKI) Assets (2017 - 2025) Analysis & Trends

Niki BioSolutions (NIKI) has 9 years of Assets data on file, last reported at $481065.0 in Q4 2025.

Quarterly Assets changed N/A year-over-year to $481065.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $481065.0 (changed N/A YoY) and the FY2025 annual result came in at $18.7 million, up 15.88% from the prior year.
Assets rose to $481065.0 in Q4 2025, from $410699.0 in the prior quarter.
In the past five years, Assets ranged from a high of $31.7 million in Q2 2021 to a low of $384624.0 in Q2 2025.
A 5-year average of $13.5 million and a median of $17.5 million in 2023 frame the typical range for Assets.
The widest YoY moves for Assets: up 36.06% in 2021, down 50.47% in 2021.
Tracing NIKI's Assets over 5 years: stood at $21.9 million in 2021, then retreated by 4.75% to $20.9 million in 2022, then slipped by 1.09% to $20.6 million in 2023, then plunged by 97.19% to $579833.0 in 2024, then declined by 17.03% to $481065.0 in 2025.
The last three Assets figures came in at $481065.0 (Q4 2025), $410699.0 (Q3 2025), and $384624.0 (Q2 2025), per Business Quant data.

Download Data